
GSK vs SPOT
$GSK vs $SPOT head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs SPOT: the quick read
- ·SPOT is the larger company by market cap ($106.27B vs $103.46B).
- ·SPOT has been more active on our scanner (116 vs 42 alerts in 30 days).
- ·SPOT has the smaller float (205.8M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are unknown names, so this is a like-for-like comparison and sector news tends to move them together.
- ·GSK trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 116 and 42 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
- ·GSK pays a dividend and SPOT does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and SPOT on TheDesperateTrader.
- Is GSK or SPOT the better stock?
- "Better" depends on your goal, and these two are not alike. SPOT is the larger company by market cap ($106.27B vs $103.46B). SPOT has been more active on our scanner (116 vs 42 alerts in 30 days). SPOT has the smaller float (205.8M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and SPOT?
- The differences that matter: they are similar in size ($103.46B vs $106.27B); they trade at very different share prices ($51.98 vs $537.00); GSK sits at 58% of its 52-week range against 39% for SPOT; only GSK pays a dividend; our scanner flagged GSK 42 times in the last 30 days against 116 for SPOT. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and SPOT is more active right now?
- Right now GSK is at about 1.0x its normal volume and SPOT is at about 1.3x, so SPOT is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or SPOT? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.